UBX Company Profile and Key Details
Unity Biotechnology, Inc.
UBX Stock Price Chart
Stock Price Today
Unity Biotechnology, Inc. (UBX) stock declined over -4.73%, trading at $2.12 on NASDAQ, down from the previous close of $2.22. The stock opened at $2.20, fluctuating between $2.05 and $2.35 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
South San Francisco, CA 94080
United States
Website: https://unitybiotechnology.comContact: 650 416 1192About Company
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.
Company Information
| Employees | 19 |
| Beta | 0.83 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Unity Biotechnology, Inc. (NASDAQ: UBX) stock price is $2.12 in the last trading session. During the trading session, UBX stock reached the peak price of $2.35 while $2.05 was the lowest point it dropped to. The percentage change in UBX stock occurred in the recent session was -4.73% while the dollar amount for the price change in UBX stock was -$0.11.
The NASDAQ listed UBX is part of Biotechnology industry that operates in the broader Healthcare sector. Unity Biotechnology, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Daohong Zhou M.D.
Founder
Dr. Judith Campisi Ph.D.
Founder
Dr. Jan M. van Deursen
Founder
Dr. Anirvan Ghosh Ph.D.
Chief Executive Officer & Director
Dr. Przemyslaw Sapieha Ph.D.
Chief Scientific Advisor
Dr. Nathaniel E. David A.B., Ph.D.
Co-Founder & Executive Director
Mr. Nathan Guz Ph.D.
Vice President of Operations
Mr. Alexander Hieu Nguyen J.D.
Gen. Counsel & Corporation Sec.
Ms. Lynne Marie Sullivan
Chief Financial Officer & Head of Corporation Devel.
UBX's closing price is 136.17% higher than its 52-week low of $0.94 where as its distance from 52-week high of $3.10 is -28.39%.
Number of UBX employees currently stands at 19.
Official Website of UBX is: https://unitybiotechnology.com
UBX could be contacted at phone 650 416 1192 and can also be accessed through its website. UBX operates from 285 East Grand Avenue, South San Francisco, CA 94080, United States.
UBX stock volume for the day was 133K shares. The average number of UBX shares traded daily for last 3 months was 226.51K.
The market value of UBX currently stands at $35.64M with its latest stock price at $2.12 and 16.85M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com